In order to identify novel single nucleotide polymorphisms (SNPs), we sequenced a 940 bp region of the 5 ′ flanking region of the IL-6 gene in 63 normal African-Americans. We identified a biallelic (G/C) SNP at position −573 relative to the transcription start site (−573C allele frequency 0.095). This SNP, together with SNPs at −598 and −174, allows identification of five probable haplotypes. Haplotypes containing the −174C allele, which has been associated with lower plasma IL-6 levels, were uncommon (4%). These haplotypes may influence IL-6 gene transcription and thus may contribute to racial differences in the prevalence of inflammatory diseases.
Introduction, Results, and Discussion
Nucleotide variations in the regulatory regions of cytokine genes may have important influences on gene transcription levels and influence susceptibility and severity of autoimmune diseases such as rheumatoid arthritis. We chose to study the IL-6 gene because of its multiple endocrine, metabolic, and immunological effects. 1 To allow the determination of genotypes at two known single nucleotide polymorphisms (SNPs) (at −174 and −598 relative to the transcription start site) and also the identification of potential novel SNPs, we sequenced a 940 bp fragment of the 5′ flanking region (from −845 to exon 1). Sixty-three normal African-American (A-A) individuals were analyzed: 10 individuals from the Birmingham, Alabama area who reported no history of autoimmune disease, and 53 A-A who served as controls for the Grady African-American Rheumatoid Arthritis (GAARA) cohort. GAARA controls were healthy Georgia residents who filled in a three-generation report of self, parental and grandparental race using 'Black', 'White', 'Native American/Alaskan Native', and 'Asian/Pacific Islander' as choices. All reported 'black race' for self and all relatives.
We discovered a G/C SNP at position −573. allele −573G and 0.095 for allele −573C. The same sequencing reactions also revealed the alleles of the previouslydescribed IL-6 SNPs in our population. Allele frequencies at the −598, 2 and −174 3 SNPs were as follows: −598G (0.952), −598A (0.048); −174G (0.96), −174C (0.04). Because sequencing of cloned PCR products was not performed, it was not possible to definitively assign haplotypes in individuals heterozygous at one or more SNPs. However, we were able to definitively identify two haplo types (−598G/−573G/−174G and −598G/−573C/−174G) because at least one individual was homozygous at each of the three SNPs, and we termed these haplotypes '1' and '2' respectively. For donors heterozygous at two of the three SNPs, we inferred haplotypes by assuming one haplotype was G/G/G (the most frequent haplotype, at 84.1%). Thus, three additional tentative haplotypes were deduced: A/G/C, A/G/G, and G/G/C, and termed haplotypes '3', '4' and '5'. The most common haplotypes were haplotype 1 (G/G/G: 84.1%) and haplotype 2 (G/C/G: 9.5%); the A/G/C, A/G/G, and G/G/C haplotypes were uncommon (2.4%, 2.4%, and 1.6%, respectively, Table 1A ). Approximately three-quarters of all A-A individuals carried two copies of haplotype 1 (Table 1B) .
The influence of the novel SNP at −573 or of particular haplotypes on transcription of the IL-6 gene are unknown. Using an internet-based software program, Transcription Element Search Software (http://www. cbil.upenn.edu/), a potential c-Myb binding site [consensus (CT)AAC(GT)G(ACT)(ACT)] was identified immediately adjacent to the −573 SNP. c-Myb is an oncoprotein important in hematopoiesis and myelopoiesis; it binds to multiple sites in the promoters of target genes. Further work will determine whether this potential cMyb site is active in the human IL-6 promoter and if so, whether it is affected by either of the −573 alleles.
The low frequency of the −174C allele in our A-A sub- PCR was performed using 500 ng of genomic DNA added to standard PCR buffer using Taq DNA polymerase. Two overlapping fragments spanning the 940 bp region were amplified. In one amplification, the primer sequences were: MO-21 5′-AAACAGTGGTGAAGA GACTCAGTG-3′ (sense) and MO-22 5′-AAAGAGTAAAGCTGAAGTCATGCA-3′ (antisense). In the other reaction, the primer sequences were: MO-8 5′-TGCATGACTTCAGCTTTACTCTTT-3′ (sense) and MO-16 5′-GCTAAGGATTTCCTGCACTTACTT-3′ (antisense). Fluorescence-based automated cycle sequencing of purified PCR products was performed using the Big DyeTM terminator chemistry (PE Applied Biosystems, Foster City, CA, USA), which is optimized for heterozygote detection. Sequences were compared to reported sequences (Genbank Accession Nos. Y00081, AF039224-039228, AF48692, AF005485). Genotyping of the −174 SNP was performed by sequence analysis as described above in 20 of the 63 subjects and by allele-specific PCR (AS-PCR) in the remaining 43 subjects. Sense primers for AS-PCR were: MO-12 5′-TTTTCCCCCTAGTTGTGTCTTACG-3′ (−174G allele), and MO-13 TTTTCCCCCTAGTTGTGTCTTACC (−174C allele). The antisense primer MO-16 5′-GCTAAGCATTTCCTGCACTTACTT-3′ was used in both amplifications.
jects (0.04) is similar to that in Afro-Carribeans and different from Caucasians. 3 In the study by Fishman et al, 3 the −174C allele frequency was 0.403 in Caucasians from the United Kingdom and 0.05 in Afro-Caribbeans. In an analysis of 104 healthy Caucasians, the −174C allele frequency was found to be 0.41. 4 In normal individuals, the presence of the C allele at the −174 SNP appears to correlate with lower plasma IL-6 levels. 3 In addition, in vitro studies using reporter gene constructs showed that the −174C allele is associated with lower IL-6 promoter activity than the −174G allele. 3 These findings, in conjunction with the low −174C allele frequency in A-A individuals, suggests that racial differences in IL-6 genotypes may be of functional significance.
In summary, we report a novel G/C SNP at position −573 of the human IL-6 promoter and its distribution in a population of 63 healthy, unrelated individuals of African-American race. In the context of the two existing SNPs in this region, these have allowed us to identify five putative IL-6 promoter haplotypes. Multiple factors, including the −573 SNP, other SNPs, the putative c-myb binding site, or 5′ haplotypes may individually or interactively influence IL-6 gene transcription in health or disease. These possibilities, and further confirmation of racial differences in the distribution of IL-6 gene polymorphisms will be the focus of future clinical, molecular, and genetic studies.
